TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
+20.4%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$815M
AUM Growth
+$156M
(+24%)
Cap. Flow
+$89.5M
Cap. Flow
% of AUM
10.98%
Top 10 Holdings %
Top 10 Hldgs %
43.07%
Holding
100
New
33
Increased
19
Reduced
13
Closed
5
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$20M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$14.2M |
| 3 |
Heron Therapeutics
HRTX
|
$13.2M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$13.2M |
| 5 |
Insmed
INSM
|
$10.8M |
Top Sells
| 1 |
Veru
VERU
|
$40.7M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$30.6M |
| 3 |
Altimmune
ALT
|
$12.8M |
| 4 |
BioAtla
BCAB
|
$10.8M |
| 5 |
Inspirato
ISPO
|
$6M |
Sector Composition
| 1 | Healthcare | 96.03% |
| 2 | Communication Services | 1.61% |
| 3 | Consumer Discretionary | 0.82% |
| 4 | Consumer Staples | 0.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ionis Pharmaceuticals
IONS
$9.84B
| $8.85M | 1.08% |
200,000
| – | – |
|
27
Nkarta
NKTX
$154M
| $8.72M | 1.07% |
662,872
+312,872
| +89% | +$4.12M |
|
28
AstraZeneca
AZN
$254B
| $8.23M | 1.01% |
+150,000
| New | +$8.23M |
|
|
ALLK
29
DELISTED
Allakos
ALLK
| $8.1M | 0.99% |
1,323,393
| – | – |
|
30
Day One Biopharmaceuticals
DAWN
$769M
| $8.01M | 0.98% |
+400,000
| New | +$8.01M |
|
31
Cullinan Oncology
CGEM
$410M
| $8M | 0.98% |
624,016
+14,785
| +2% | +$190K |
|
|
RVNC
32
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.76M | 0.95% |
+287,500
| New | +$7.76M |
|
33
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $7.7M | 0.94% |
600,000
| – | – |
|
34
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $7.21M | 0.88% |
750,000
| – | – |
|
|
IMGN
35
DELISTED
Immunogen Inc
IMGN
| $7.17M | 0.88% |
1,500,000
| – | – |
|
36
Enanta Pharmaceuticals
ENTA
$192M
| $7.14M | 0.88% |
137,700
| – | – |
|
37
Ascendis Pharma
ASND
$12.4B
| $6.82M | 0.84% |
+66,090
| New | +$6.82M |
|
|
TCRR
38
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $6.74M | 0.83% |
3,741,606
+100,000
| +3% | +$180K |
|
|
CNCE
39
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.72M | 0.82% |
+1,003,017
| New | +$6.72M |
|
40
BridgeBio Pharma
BBIO
$10.2B
| $5.82M | 0.71% |
+585,424
| New | +$5.82M |
|
41
Arcus Biosciences
RCUS
$1.26B
| $5.23M | 0.64% |
200,000
| – | – |
|
42
CytomX Therapeutics
CTMX
$350M
| $5.08M | 0.62% |
3,500,000
+2,445,327
| +232% | +$3.55M |
|
43
Celldex Therapeutics
CLDX
$1.53B
| $4.5M | 0.55% |
+160,219
| New | +$4.5M |
|
|
GNFT
44
Genfit
GNFT
$205M
| $4.37M | 0.54% |
1,197,522
-63,920
| -5% | -$233K |
|
|
TSVT
45
DELISTED
2seventy bio
TSVT
| $4.37M | 0.54% |
300,000
| – | – |
|
46
BioNTech
BNTX
$27.4B
| $4.05M | 0.5% |
30,000
-10,000
| -25% | -$1.35M |
|
47
Alibaba
BABA
$319B
| $4M | 0.49% |
50,000
| – | – |
|
48
Orchestra BioMed
OBIO
$147M
| $3.89M | 0.48% |
+392,500
| New | +$3.89M |
|
49
Aldeyra Therapeutics
ALDX
$336M
| $3.74M | 0.46% |
+700,000
| New | +$3.74M |
|
50
Fortress Biotech
FBIO
$98.2M
| $3.61M | 0.44% |
279,632
+56,779
| +25% | +$732K |
|